Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-30

Clinical Trial Update: Value of IUS in Predicting Vedolizumab Efficacy and Assessing Transmural Healing in Early Crohn's Disease: A Multicenter, Prospective Study

View source ↗

Summary

A multicenter, prospective trial evaluating whether intestinal ultrasound can predict response to vedolizumab and demonstrate transmural healing in early Crohn'…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vedolizumab (vedolizumab)

Snippet

Sponsor: The Third Xiangya Hospital of Central South University | Conditions: Crohn Disease (CD), Vedolizumab | Status: RECRUITING